Ignite Creation Date:
2024-05-05 @ 11:24 AM
Last Modification Date:
2024-10-26 @ 9:06 AM
Study NCT ID:
NCT00023920
Status:
TERMINATED
Last Update Posted:
2013-01-23
First Post:
2001-09-13
Brief Title:
Bevacizumab Idarubicin and Cytarabine in Treating Patients With Blast Phase Chronic Myelogenous Leukemia
Sponsor:
Organization:
National Cancer Institute NCI